Cargando…
Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing
The currently used pharmacogenetic genotyping assays offer limited haplotype information, which can potentially cause specific functional effects to be missed. This study tested if Targeted Locus Amplification (TLA), when using non-patient-specific primers combined with Illumina or Nanopore sequenci...
Autores principales: | Tilleman, Laurentijn, Rubben, Kaat, Van Criekinge, Wim, Deforce, Dieter, Van Nieuwerburgh, Filip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587992/ https://www.ncbi.nlm.nih.gov/pubmed/36273027 http://dx.doi.org/10.1038/s41598-022-22499-0 |
Ejemplares similares
-
Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies’ adaptive sampling
por: Deserranno, Koen, et al.
Publicado: (2023) -
Cas9 targeted nanopore sequencing with enhanced variant calling improves CYP2D6-CYP2D7 hybrid allele genotyping
por: Rubben, Kaat, et al.
Publicado: (2022) -
Nanopore Sequencing of a Forensic STR Multiplex Reveals Loci Suitable for Single-Contributor STR Profiling
por: Tytgat, Olivier, et al.
Publicado: (2020) -
Kinship analysis on single cells after whole genome amplification
por: Weymaere, Jana, et al.
Publicado: (2020) -
Illumina sequencing of 15 deafness genes using fragmented amplicons
por: Van Nieuwerburgh, Filip, et al.
Publicado: (2014)